CARDIOVASCULAR AND RENAL HEMODYNAMIC EFFECTS OF DOPEXAMINE: COMPARISON WITH DOPAMINE
Open Access
- 1 September 1990
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 65 (3) , 380-387
- https://doi.org/10.1093/bja/65.3.380
Abstract
We have studied the effects of dopexamine and dopamine on systemic and renal haemodynamics in 20 male patients undergoing elective coronary artery bypass surgery. Patients were allocated randomly to two groups (n = 10) who were treated with incremental doses of either dopexamine 1, 2 and 4 μg kg−1 min−1, or dopamine 2.5 and 5 μg kg−1 min−1, each dose being maintained for 15 min. Measurements were performed before administration of the drug and at the end of the infusion period at each dose. Fentanyl and midazolam were used as anaesthetic agents. Renal blood flow was measured with the argon washin technique. Dopexamine 4 μg kg−1 min−1 produced an increase in cardiac index of 117% caused by a 65% reduction in afterload and an increase in heart rate by 61%. Dopamine 5 μg kg−1 min−1 caused a 40% increase in cardiac index as a result of an increase in stroke volume. Renal vascular resistance decreased more than systemic vascular resistance with dopamine. With dopexamine, the increase in renal blood flow (66%) was less than the increase in cardiac index, while renal vascular resistance and systemic vascular resistance declined to almost the same extent. The results show that dopexamine exerts systemic and renal effects mainly via stimulation of β2-receptors. An action of dopexamine at renal DA1-receptors could not be demonstrated in this study.Keywords
This publication has 12 references indexed in Scilit:
- Inhibition of Uptake1 by dopexamine hydrochloride in vitro)British Journal of Pharmacology, 1987
- Beneficial Haemodynamic Effects of Intravenous Dopexamine in Patients with Low-Output Heart FailureJournal of Cardiovascular Pharmacology, 1987
- Enhanced dopamine renal responsiveness in patients with hypertensionClinical Pharmacology & Therapeutics, 1986
- Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.Circulation Research, 1986
- Short-term haemodynamic effects of dopexamine in patients with chronic congestive heart failureEuropean Heart Journal, 1986
- Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.Heart, 1985
- The effects of dopexamine on the cardiovascular system of the dogBritish Journal of Pharmacology, 1985
- Dopexamine: a novel agonist at peripheral dopamine receptors and β2‐adrenoceptorsBritish Journal of Pharmacology, 1985
- Direct Renal Vasodilatation Produced by Dopamine in the DogCirculation Research, 1965
- Effects of Dopamine in Man: Augmentation of Sodium Excretion, Glomerular Filtration Rate, and Renal Plasma Flow*Journal of Clinical Investigation, 1964